Quantum thermal machines with single nonequilibrium environments B Leggio, B Bellomo, M Antezza
Physical Review A 91 (1), 012117, 2015
51 2015 Knowledge management and information tools for building maintenance and facility management C Talamo, M Bonanomi
Springer International Publishing, 2015
41 2015 A measurement of the Higgs boson mass in the diphoton decay channel AM Sirunyan, A Tumasyan, W Adam, F Ambrogi, T Bergauer, ...
Physics Letters B, 135425, 2020
35 2020 Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model M Bonanomi, A Natalello, C Visentin, V Pastori, A Penco, G Cornelli, ...
Human Molecular Genetics 23 (24), 6542-6552, 2014
32 2014 Edifici a consumo energetico zero M Bonanomi, C De Flumeri, M Lavagna
Orientamenti normativi, criteri progettuali ed esempi di Zero Energy e Zero …, 2012
30 * 2012 Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models S Valtorta, AL Dico, I Raccagni, D Gaglio, S Belloli, LS Politi, C Martelli, ...
Oncotarget 8 (68), 113090, 2017
29 2017 A hydrophobic gold surface triggers misfolding and aggregation of the amyloidogenic Josephin domain in monomeric form, while leaving the oligomers unaffected A Apicella, M Soncini, MA Deriu, A Natalello, M Bonanomi, D Dellasega, ...
PLoS One 8 (3), e58794, 2013
28 2013 Natural Compounds against Neurodegenerative Diseases: Molecular Characterization of the Interaction of Catechins from Green Tea with Aβ1–42, PrP106–126, and Ataxin‐3 Oligomers E Sironi, L Colombo, A Lompo, M Messa, M Bonanomi, ME Regonesi, ...
Chemistry–A European Journal 20 (42), 13793-13800, 2014
27 2014 Differentiation by nerve growth factor (NGF) involves mechanisms of crosstalk between energy homeostasis and mitochondrial remodeling F Martorana, D Gaglio, MR Bianco, F Aprea, A Virtuoso, M Bonanomi, ...
Cell death & disease 9 (3), 1-16, 2018
24 2018 Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent toxicity in neural … C Visentin, F Pellistri, A Natalello, J Vertemara, M Bonanomi, E Gatta, ...
Human Molecular Genetics 26 (17), 3271-3284, 2017
17 2017 How Epigallocatechin‐3‐gallate and Tetracycline Interact with the Josephin Domain of Ataxin‐3 and Alter Its Aggregation Mode M Bonanomi, C Visentin, A Natalello, M Spinelli, M Vanoni, C Airoldi, ...
Chemistry–A European Journal 21 (50), 18383-18393, 2015
17 2015 Study of excited states decaying to in proton-proton collisions at s= 13TeV AM Sirunyan, A Tumasyan, W Adam, F Ambrogi, T Bergauer, ...
Physics Letters B, 135345, 2020
16 2020 Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome M Bonanomi, S Mazzucchelli, A D’Urzo, M Nardini, PV Konarev, ...
The international journal of biochemistry & cell biology 51, 58-64, 2014
15 2014 Measurements of production cross sections of WZ and same-sign WW boson pairs in association with two jets in proton-proton collisions at CMS collaboration
arXiv preprint arXiv:2005.01173, 2020
14 2020 Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells L Minafra, N Porcino, V Bravatà, D Gaglio, M Bonanomi, E Amore, ...
Scientific reports 9 (1), 1-16, 2019
13 2019 The toxic effects of pathogenic ataxin-3 variants in a yeast cellular model M Bonanomi, C Visentin, G Invernizzi, P Tortora, ME Regonesi
PloS one 10 (6), e0129727, 2015
11 2015 Measurements of tt¯ H Production and the CP Structure of the Yukawa Interaction between the Higgs Boson and Top Quark in the Diphoton Decay Channel CMS collaboration
Physical review letters 125 (6), 061801, 2020
9 2020 Measurements of AM Sirunyan, A Tumasyan, W Adam, F Ambrogi, T Bergauer, ...
Physical review letters 125 (6), 061801, 2020
9 2020 Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study D Gaglio, S Valtorta, M Ripamonti, M Bonanomi, C Damiani, S Todde, ...
Oncotarget 7 (32), 52017, 2016
9 2016 Measurement of the AM Sirunyan
TBD, 2020
7 2020 